An Evening With the Experts: Discussion on the Evolving Immunotherapy Paradigm for Non-Small-Cell Lung Cancer

Get up to date on the latest advances in immunotherapy for the management of NSCLC&mdash from early-stage to advanced disease&mdash with this educational program featuring an on-demand webcast and downloadable slidesets from a live CCO symposium where experts discuss the latest clinical data in the context of a series of patient cases along with future directions. In a companion FAQ commentary experts answer audience questions from the live program.

Share

Program Content

Activities

IO for Advanced NSCLC
The Evolving Role of Immunotherapy in Advanced NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

IO for Early-Stage NSCLC
Immunotherapy in Nonmetastatic NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

IO for Special Populations/Future Directions
Immunotherapy in Special Patient Populations and Future Directions
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

No activities added yet

Activities

FAQs on ICIs in NSCLC
Expert Answers to FAQs on Immune Checkpoint Inhibitors for NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 26, 2022

Expires: August 25, 2023

Faculty

cover img faculity

Julie Brahmer, MD

Associate Professor of Oncology
Oncology/Upper Aerodigestive Cancer Program
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

cover img faculity

Natasha Leighl, MD, MMSc, FRCPC, FASCO

Lung Medical Oncology Site Lead
OSI Pharmaceuticals Foundation Chair
Princess Margaret Cancer Centre
Professor of Medicine
University of Toronto
Toronto, Canada

cover img faculity

Jarushka Naidoo, MB BCH BAO, MHS

Consultant Medical Oncologist
Beaumont Hospital/RCSI University of Health Sciences
Dublin, Ireland
Adjunct Professor of Oncology
Sidney Kimmel Comprehensive
Johns Hopkins University
Baltimore, Maryland

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Lilly

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme